Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-16-019989)

Filing Details

Accession Number:: 0000899243-16-019989
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-16 06:11:05
Reporting Period:: 2016-05-12

Filing Date:: 2016-05-16
Accepted Time:: 2016-05-16 06:11:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1399529	Dicerna Pharmaceuticals Inc	DRNA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1598480	B James Weissman	C/O Dicerna Pharmaceuticals, Inc. 87 Cambridgepark Drive Cambridge MA 02140	Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-12	300	$3.24	15,100	No	4	P	Direct
Common Stock	Acquisiton	2016-05-12	530	$3.29	15,630	No	4	P	Direct
Common Stock	Acquisiton	2016-05-12	4,170	$3.29	19,800	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).